LitAlert ~~ GeneLit.com

    • Talazoparib in BRCA-mutated advanced breast cancer: is earlier better?
    • Boulos M, Moujaes E, Nsouli G, Tfayli A, Kourie HR.
    • Pharmacogenomics. 2022 May 24. doi: 10.2217/pgs-2022-0011. Epub ahead of print.
    • Review
    • Homologous Recombination Repair in Biliary Tract Cancers: A Prime Target for PARP Inhibition?
    • Yin C, Kulasekaran M, Roy T, Decker B, Alexander S, Margolis M, Jha RC, Kupfer GM, He AR.
    • Cancers (Basel). 2022 May 23;14(10):2561. doi: 10.3390/cancers14102561.
    • Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer.
    • Van Baelen K, Geukens T, Maetens M, Tjan-Heijnen V, Lord CJ, Linn S, Bidard FC, Richard F, Yang WW, Steele RE, Pettitt SJ, Van Ongeval C, De Schepper M, Isnaldi E, Nevelsteen I, Smeets A, Punie K, Voorwerk L, Wildiers H, Floris G, Vincent-Salomon A, Derksen PWB, Neven P, Senkus E, Sawyer E, Kok M, Desmedt C.
    • Ann Oncol. 2022 May 20:S0923-7534(22)01167-X. doi: 10.1016/j.annonc.2022.05.006. Epub ahead of print.
    • Review